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Mechanisms of the defect in glomerular ultrafiltration associated
with gentamicm administration. Micropuncture studies were per-
formed in three groups of Munich-Wistar rats: eight normal hydro-
penic controls (group 1) and two groups (eight rats each) which
were treated with gentamicin in doses of either 4 or 40 mg/kg/day
for ten days (groups 11 and Ill, respectively). Following gentamicin
administration, values for single nephron (SN) GFR were reduced
markedly, from the control mean of 31 0.7 (SEM) nlimin to 22.4
1.5 and 20.5 0.9 for groups It and III, respectively. Declines in
whole kidney GFR paralleled these falls in SNGFR. The primary
cause of the reduction in SNGFR was a marked decline in glomer-
ular capillary ultrafiltration coefficient, K, in both gentamicin
treatment groups. None of the other determinants of glomerular
ultrafiltration were significantly affected in the low dose group
(group II). In the high dose group (group Ill), however, mean
values for initial glomerular plasma flow rate and mean transglo-
merular hydraulic pressure difference were significantly lower
than in the control group, accounting for the somewhat greater
decline in SNGFR observed in group III. Electron microscopic
examination of kidney tissue from rats treated with both doses of
gentamicin revealed no obvious abnormalities of the glomerular
capillary wall, whereas the previously described morphologic
aberrations of proximal convoluted tubule cells were readily
demonstrable.
Mécanisme de l'altération de l'ultra-filtration glomérulaire asso-
ciée a l'administration de gentamicine. Afin de définir l'altération
de l'ultra-flltration associée a l'administration de gentamicine trois
groupes de rats Munich-Wistar ont été étudieés par microponc-
tions: 8 contrôles hydropeniques (groupe I) et deux groupes de huit
rats chacun traités par la gentamicine aux doses de 4 (groupe 11) ou
40 (groupe Ill) mg/kg/jour pendant dix jours. Après l'adminis-
tration de gentamicine les valeurs des debits de filtration
des néphrons (SNGFR) ont été considérablement rCduites de 31
0,7 (sEM) ni/mm a 22,4 1,5 et 20,5 0,9 pour les groupes II et
III, respectivement. Le debit de filtration glomérulaire du rein
entier a diminué parallèlement. La cause essentielle de Ia réduc-
tion de SNGFR est une diminution importante de Kf dans les deux
groupes traités par Ia gentamicine, Aucun des autres determinants
de l'ultra-filtration glomérulaire n'est affecté significativement
dans le groupe II. Dans le groupe III. cependant, les valeurs
moyennes du debit plasmatique glomérulaire initial et de Ia pres-
sion hydraulique transglomérulaire sont significativement infer-
ieures aux contrôles, rendant compte de la plus grand diminution
de SNGFR observée dans le groupe III. L'étude en microscopic
electronique du tissu renal des rats traités par l'une ou l'autre dose
de gentamicine n'a rCvélé aucune anomalie majeure de Ia paroi du
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capillaire glomerulaire alors que les modifications antérieurement
décrites des cellules du tube contourné proximal sont évidentes.
It is now generally recognized that gentamicin, an
aminoglycoside antibiotic commonly employed clini-
cally in the treatment of life-threatening gram-nega-
tive bacterial infections, is capable of producing seri-
ous nephrotoxic side-effects in man 111—3]. The renal
injury seen clinically in association with gentamicin
administration, as well as in animals given this anti-
biotic, is characterized functionally by polyuria and
substantial reduction in glomerular filtration rate
(GFR), and ultrastructurally by damage to proximal
tubule epithelia 111—151. Although several investiga-
tions have been carried out in an effort to character-
ize the mechanisms of these nephrotoxic side-
effects, an explanation for the decline in GFR has yet
to be provided. The present study was therefore
undertaken in the Munich-Wistar rat to examine
directly the effects of gentamicin administration on
the determinants of glomerular ultrafiltration.
Methods
Micropuncture studies. In vivo micropuncture
experiments were performed on 24 female and male
Munich-Wistar rats (body wt, 182 to 304 g) having
free access to water and a standard rat pellet diet.
Three groups of rats were studied: group I, eight
normal hydropenic control rats which were given
daily i.p. sham-injections of isotonic saline; group II,
a separate group of eight rats which were given
gentamicin i.p. in a dose of 4 mg/kg of body wt per
day for ten days; and group III, an additional group
of eight rats which received 40 mg/kg/day of gentami-
cm i.p. for ten days.
On the 11th day, rats were anesthetized with mac-
tin (100 mg/kg of body wt, ip.), placed on a tempera-
ture-regulated micropuncture table, and prepared for
micropuncture by using procedures described previ-
ously [16]. The left ureter was catheterized with
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PE-lO polyethylene tubing to allow collection of
urine. After completion of survery, inulin in isotonic
sodium chloride (7 g/100 ml) was infused i.v. for 60
mm, after which exactly timed (1 to 2 mm) samples
of tubule fluid were collected from surface proximal
convolutions of two or three nephrons for determina-
tion of flow rate and inulin concentration, thus per-
mitting calculation of single nephron glomerular fil-
tration rate (SNGFR). Inulin concentrations in
tubule fluid were measured, using the method of
Vurek and Pegram [17].
In addition to tubule fluid samples, microsamples
of blood from two or three superficial efferent arteri-
oles were obtained, as described by Brenner et al
[18], and were analyzed for total protein concentra-
tion by using a microadaptation of the method of
Lowry et al [19]. Samples from femoral arterial
blood plasma, taken to provide an estimate of pre-
glomerular protein concentration, were analyzed
similarly. From these measurements of protein con-
centration (C) in afferent and efferent arteriolar plas-
ma (CA and CE, respectively), values for afferent and
efferent arteriolar oncotic pressures ([IA and HE)
could be calculated [20]. These estimates of pre- and
postglomerular plasma protein concentration permit
calculation of the single nephron filtration fraction
(SNFF) and initial glomerular plasma flow rate (QA),
using equations given elsewhere [16]. Hydraulic
pressures were measured within single superficial
glomeruli (P0), as well as in surface proximal tubules(). efferent arterioles (PEA), and peritubular capil-
laries (Pa), using the servo-null micropipette trans-
ducer technique of Wiederhielm et al [21].
Throughout all micropuncture experiments, which
usually lasted between 30 and 45 mm, urine and
femoral arterial blood samples were obtained for
estimation of inulin concentration, employing the
macroanthrone method of Führ, Kaczmarczyk, and
KrUttgen [22], thus permitting calculation of whole
kidney GFR. Femoral arterial pressure (AP) was
monitored throughout each experiment via an elec-
tronic transducer (P23Db, Statham Instruments,
Oxnard, CA) connected to a direct writing recorder
(7702B, Hewlett-Packard Co., Palo Alto, CA).
Microinjection studies. In addition to these micro-
puncture studies, microinjections with tritiated (3H)
inulin were performed in a separate group of five
gentamicin-treated rats (two receiving 4 mg/kg/day;
three receiving 40 mg/kg/day, for ten days). These
additional studies were performed to assess the relia-
bility of inulin as a marker for GFR, in view of the
extensive proximal tubule cell damage that occurs
with gentamicin administration. In these experi-
ments, ureters from both kidneys were catheterized
with PE-50 polyethylene tubing. Modest diuresis
was induced by a continuous infusion of 5% mannitol
in 0.85% sodium chloride at the rate of 6 mI/hr in
order to permit rapid, serial urine collections.
Known volumes (3 to 10 nI) of nigrosin-stained 3H-
inulin in isotonic sodium chloride were injected into
early proximal tubules of the left kidney, using
sharpened glass micropipettes with outer tip dia-
meters of 6 to l0p. Injection time ranged from 30 to 90
seconds, depending on the volume of injectate. The
injection rate was controlled to avoid retrograde flow
of isotope. Using a calibrated transfer pipette,
known volumes of isotope were transferred to 1)
sharpened microinjection pipettes, and 2) unshar-
pened pipettes which were used for standarization of
activity of the injectate. The experimental protocol
was as follows: Immediately prior to each micro-
injection, two 2-mm urine collections from the experi-
mental (left) kidney were made directly into counting
vials. One of these collections served as a blank to
measure background radioactivity in urine. A stan-
dard volume of isotope, equal to that which was
subsequently injected into the test tubule, was
deposited into the second vial. Isotope was then
injected into an early proximal tubule, and three
consecutive 2-mm urine collections were made from
the experimental kidney, followed by one 6-mm
urine collection. Two simultaneous 6-mm urine col-
lections were also obtained from the contralateral
(right) kidney. A period of 10 to 15 minutes then was
allowed to elapse before the next microinjection was
performed to ensure that background radioactivity
was minimal. Isotonic sodium chloride was added to
each urine collection to achieve a final volume of 3
ml, the latter having been mixed thoroughly with 7
ml of Aquasol (New England Nuclear, Boston, MA)
to ensure even dispersion of isotope. The activity of
3H was measured in a liquid scintillation spectro-
meter (Packard Inst. Co., Downers Grove. IL). The
percentage of recovery of injected H-inu[in was cal-
culated as follows:
% recovery
—
(total isotope in urine after injection)
>< 100(isotope in injectate)
—
All samples were corrected for background activity.
Morphological studies. The kidneys from a sepa-
rate group of normal hydropenic control rats (N =3)
and from two groups of gentamicin-treated rats (four
each, receiving either 4 or 40 mg/kg/day for ten days)
were prepared for electron microscopic examination.
These kidneys were fixed by perfusion with a 1.25%
cacodylate-buffered glutaraldehyde solution (pH,
7.4; at 110 mm Hg). Cortical tissue was post-fixed in
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Table 1. Summary of the measured determinants of glomerular ultrafiltration in normal (group I) and low and high dose groups II and III)
gentamicin-treated rats"
GFR F FGC PT CA CE 11A 11E flE/P SNFF SNGFR QA Kf
Rat no. mI/mm mm Hg g/100 ml mm Hg ni/mm nlI(s mm Hg)
Groupi(N =8)
0.94 0.41
1.04 0.42
1.07 0.44
0.95 0.40
0.98 0.38
1.16 0.44
0.99 0.35
0.97 0.41
1.01 0.41
0.03 0.01
73.6
71.2
76.1
69.3
89.2
67.0
90.0
74,9
76.4
3.1
2
3
4
5
6
7
8
9
10
11
12
13
0.051
0,056b
0073b
0049b
0059b
0.083'
0.062b
0048b
0.060
0.004
0.91 110 48 13
0.73 110 46 11
1.13 100 44 10
0.79 130 47 11
1.12 125 47 12
0.95 115 44 12
1.30 115 44 10
1.07 115 47 11
Mean 1.00 115 46 11
0.07 3 1 1
0.48 125 52 11
0.72 108 44 10
0.60 120 46 12
0.57 105 44 9
0.65 115 46 13
28.4
32.7
30.5
30.3
30.3
30.3
34,5
32.6
33.5
27.8
27.8
34.9
32.9
33,9
26.6
32.5
29.5
32.3
30.7
31.5
30.4
30.9
30.7
31.0
0.7
20.7
18.4
19.6
26.2
23.5
24.9
21.2
25.2
23.2
17.6
22.3
20.0
22.6
26.9
24.8
26.6
65.6 0.0180.30
0.36
0.38
0.35
0.39
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0.036
0.033
31.4
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Table 1. (Cont'd) Sum mary of the measured determinants of glomerular ultrafiltration in normal (group 1) and low and high dose (groups 11 and
111) gentamicin-treated ratsa
GFR A PG( PT CA CF 1IA flE HjP SNFF SNGFR QA Kf
Rat no. mI/mm mm Hg gIl00 ml mni Hg nI/,nin nI/(s mm Hg)
17.9
7.0 2.0
15 0.65 110 44 8 5.2 7.0 16.5 25.6 0.71 0.26 14.9 57.9 0.016
21.9
8.0 21.8
9.4 24.4
16 0.67 120 47 11 5.8 8.7 19.3 36.3 1.00 0.33 22.7 68.1 Ø046b
Mean 0.62 115 46 11 5.1 7.6 16.1 29.5 0.83 0.33 22.4 67.8 0.032
0.03 2 1 1 0.2 0.2 0.8 1.3 0.04 0.02 1.5 4.9 0.004
P valuee (Gps. I and 11)
<0.001 NS NS NS NS <0.005 NS <0.005 <0.005 <0.005 <0.001 NS <0.001
Group III (N 8)
7.4 20.8
7.3 22.4
17 0.56 140 48 14 4.5 7.4 13.5 27.9 0.82 0.39 21.6 55.1 0.027
7.7 21.9
7.5 18.5
18 0.52 115 48 18 5.6 7.6 18.4 29.2 0.97 0.28 20.2 71.6
7.4 17.2
8.1 22.6
19 0.62 110 46 14 4.6 7.8 13.9 30.4 0.95 0.41 19.9 48.5 0.039
25.5
7.5 23.1
7.3 24.2
20 0.45 112 46 15 5.4 7.4 17.4 28.0 0.90 0.27 24.3 90.0 0.053
7.5 22.3
7.5 24.8
21 0.55 110 46 12 5.0 7.5 15.6 28.5 0.84 0.33 23.6 70.9 0.034
7.3
7.6 20.1
22 0.63 115 46 13 4.7 7.4 14.3 27.9 0.84 0.36 20.1 55.7 0.028
7.6 16.1
7.8 18.1
23 0.35 105 48 13 4.6 7.7 13.9 29.8 0.85 0.40 17.1 42.4 0.028
7.6
7.3 15.3
7.6 19.7
24 0.37 110 42 12 4.6 7.5 13.9 28.5 0.95 0.39 17.5 45.2 0.039
Mean 0.51 115 46 14 4.9 7.5 15.1 28.8 0.89 0.35 20.5 59.9 0.038
0.04 4 1 1 0.2 0.1 0.6 0.3 0.02 0.02 0.9 5.8 0.004
P valuec (Gps. I and 111)
<0.001 NS NS <0.005 NS <0.001 NS <0.001 <0.005 <0.05 <0.001 <0.025 <0.005
P valu& (Gps. II and Ill)
<0.025 NS NS <0.005 NS NS NS NS NS NS NS NS NS
a Abbreviations used are: AP, femoral arterial pressure: PGC, hydraulic pressure within single capillaries of superficial glomeruli; PT,
hydraulic pressure within surface proximal tubules; CA and CE, protein concentration in afferent and efferent arteriolar plasma; 11A and H,
afferent and efferent arteriolar oncotic pressures; P, mean transglomerular hydraulic pressure difference; QA, initial glomerular plasma flow
rate; K, glomerular capillary ultrafiltration coefficient; N, number of animals studied.
IF Under conditions of filtration pressure equilibrium, i.e,, -E/IP 1.00, only a minimum value for Kf can be calculated.
Student's t test for unpaired data.
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Normal Gentamicin Gentamicin
hydropenia 4 mg/kg/day 40 mg/kg/day(N= 8) )N= 8) (N=8)
Fig. 1. Summary of the determinants of glomerular ultrafiltration
in normal hydropenic control rats and two groups of rats treated
daily for ten days with gentamicin in doses of 4 or 40 mg/kg/day.
QA denotes initial glomerular plasma flow; K1, the glomerular
capillary ultrafiltration coefficient. AU data are given as means 1
SEM.
1% osmium tetroxide for 90 mm, dehydrated in alco-
hol, and embedded in Epon 812. Thin sections were
cut with diamond knives and stained on copper grids
with lead citrate and uranyl acetate. Multiple sec-
tions from each animal were examined on an electron
microscope (Phillips 201, Phillips Electronic Instru-
ments, Eindhoven, The Netherlands).
Results
Micropuncture studies. Individual and mean val-
ues for whole kidney GFR, A, SNGFR and the
pressures and flows determining glomerular ultrafil-
tration are summarized in Table 1 and Figure 1. In
both groups of gentamicin-treated rats, little weight
change was observed during the ten-day injection
period, each group gaining, on average, 4 4 g of
body weight. As shown in Table 1, values for whole
kidney GFR averaged 1.00 0.07 (sEM) ml/minl
kidney in group I control rats and were reduced
following treatment with both low and high doses of
gentamicin to mean values of 0.62 0.03 and 0.51
0.04 mllminlkidney for groups II and III, respective-
ly. Urine flow rates averaged 2.2 0.3, 2.0 0.2,
and 2.1 0.2 p1/mm/kidney for groups I to III,
respectively. Values for SNGFR (Table I and Fig. I,
upper panel) were significantly lower in both groups
of gentamicin-treated rats, averaging 31.0 0.7 nIl
mm in control (group I) rats and 22.4 1.5 (P <
0.001) and 20.5 0.9 nllmin (P <0.001) for groups II
and III, respectively. As shown in Table 1 and Figure
1, mean values for QA were not significantly different
in groups I and II, averaging 76.4 3.1 and 67.8
4.9 nhlmin. In group III animals, however, a signifi-
cantly lower value for QA was noted, averaging 59.9
5.8 nl/min (P <0.025). As a result of the dispro-
portionately lower values for SNGFR than QA
observed following gentamicin administration,
SNFF fell significantly, from a mean value of 0.41
0.01 in group Ito 0.33 0.02 (P <0.005) and 0.35
0.02 (P < 0.05) for groups II and III, respectively.
Mean values for arterial hematocrit were essentially
similar between control (group I) and low and high
dose gentamicin-treated rats (groups II and III),
averaging 53 1, 52 1, and 52 I vols %,
respectively.
As shown in Figure 1 (middle panel) and Table 1.
the mean glornerular transcapillary hydraulic pressure
difference, P, during normal hydropenia averaged
35 1 mm Hg, essentially equal to the mean value of
11E This equality of 11E and zP denotes achievement
of filtration pressure equilibrium. In group II rats,
treated with gentamicin in a dose of 4 mg/kg daily for
ten days, the average value for P remained essential-
ly unchanged from control (35 1 mm Hg). By con-
trast, values of 11E were reduced significantly, rela-
tive to group I, averaging 29.5 1.3 vs. 35.9 0.5
mm Hg (P < 0.005). In seven of the eight rats in
group II, the reduction in 11E was sufficient to pre-
vent achievement of filtration pressure equilibrium,
reflected by the mean value for the ratio of HE/P of
0.83 0.04 vs. 1.01 0.03 in group I (P <0.005). In
rats given the higher dose of gentamicin (group III),
filtration pressure disequilibrium again was obtained
in seven of the eight rats studied (mean llElP = 0.89
0.02), due to marked falls in 11E to a mean of 28.8
0.3 mm Hg (Table 1, Fig. 1). In contrast to group II
rats, however, there was, on average, a small but
significant concomitant decline in P (to 32 1 mm
Hg) (P < 0.025) in group III rats. This reduction in
was entirely the consequence of elevations in PT,
values averaging 14 1 mm Hg in group III rats
relative to 11 1 mm Hg in groups I and II (P <
0.0Q5). Mean values for PGC were essentially identi-
cal, on average, in all three groups of rats studied
(Table 1). Although not shown in Table 1, mean
values for P and PEA in group II rats averaged 9.0
0.7 and 16.0 0.7 mm Hg, respectively, values not
significantly different from the control mean values
40
30 •
U-(9.20a
a)
a)(00)0
I
100
SNFF 041 0.33 0.35
0.02
0.00 I I
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of 8,0 0.4 and 14.0 0.9 mm Hg. In group Ill rats,
however, P averaged 10.0 0.5 mm Hg, while the
mean value for EA was 21.0 1.4 mm Hg, both
significantly higher than the control (group I) mean
values (P < 0.05 and < 0.005, respectively). Values
for CA and, thus, UA were unaffected by either dose
of gentamicin (Table 1, Fig. 1).
Under conditions of filtration pressure equilib-
rium, as obtained in group I rats, only a minimum
value for the glomerular capillary ultrafiltration coef-
ficient, K1, may be determined, and as shown in
Table 1 and Fig. 1 (lower panel) this mean minimum
value averaged 0.06 0.004 nl/(s'mm Hg). Under
conditions of filtration pressure disequilibrium, how-
ever, which was obtained in most animals in groups
II and III, it was possible to calculate unique values
for K1, as described by Deen et al [23]. As shown in
Table I and Figure 1 (lower panel), mean values for
K1 in both groups of gentamicin-treated rats were
reduced significantly and by similar amounts, on
average to some 50% of the control minimum value.
Microinjection studies. As shown in Table 2, the
Table 2. Microinjection inulin recovery studiesa
Rat no. Tubule nos.
R
mi
ecovery of
ected inulin,
%
Genta,nicin, 4 tnglkgldav (N = 5)
Rat 1 1
2
3
101.4
93.5
95.5
Rat 2 4
5
97.6
101.1
Mean 97.8
0.7
Rat 1
Gentamici,,, 40 mg/kg/day (N
1
2
3
4
= 7)
90.0
99.0
99.0
97.0
Rat2 5
6
101.0
94.0
Rat3 7 101.4
Mean 97.3
0.6
a N denotes the number of tubules studied.
recovery of 3H-inulin microinjected into five proxi-
mal tubules of rats treated with gentamicin (4 mg/kg!
day) averaged 97.8 0.7%, while recovery of 3H-
inulin for seven microinjections in rats treated with
40 mg/kg/day averaged 97.3 0.6%. These findings
exclude the possibility of any significant transtubular
leak of inulin in these gentamicin-treated rats, there-
by validating our reliance on inulin as a marker of the
glomerular ifitration rate of water.
Morphological studies. Figure 2 shows representa-
tive electron microscopic sections through the gb-
merular capillary wall from a normal control rat and
from rats treated with 4 and 40 mg/kg/day of gentami-
cm. No consistent ultrastructural differences were
evident for any of the component layers of the gb-
merular capillary wall for the three groups examined.
In contrast to the glomerulus, morphologic changes
in proximal tubule cells were readily apparent, as
shown in Figure 3 where representative sections
through proximal tubules of these same three groups
are presented. Whereas lysosomes appeared normal
in control rats, they took on the characteristic lamel-
lated appearance of myeloid bodies in both groups of
gentamicin-treated rats. Also, some areas of the
proximal tubules exhibited a highly localized loss of
brush border in group III rats. Necrosis of proximal
tubule cells per se was not apparent with either dose
of gentamicin. Tubule cell lesions tended to be more
severe in rats treated with the high dose of
gentamicin.
Discussion
In recent years, many workers have suggested that
administration of the aminoglycoside antibiotic, gen-
tamicin, results in nephrotoxic injury in man and in a
variety of experimental animals [1—151. Some work-
ers have claimed that nephrotoxicity occurs when
renal excretory function is already compromised [1,
5—7, 10] or when massive doses of the antibiotic are
given [4—6]. On the other hand, Wilfert et al [21, and
Kahn and Stein [3] have reported that gentamicin
therapy may be associated with a high incidence of
renal dysfunction, even in patients without a pre-
vious history of kidney disease. Indeed, several
workers have demonstrated ultrastructural abnor-
malities of the proximal tubule following administra-
tion to rats and rabbits of doses of gentamicin equiv-
alent to the dose employed clinically [8, 11, 15].
The present studies also demonstrate that adminis-
tration of gentamicin, in the therapeutic dose range
(4 mg/kg/day), to otherwise healthy Munich-Wistar
rats results in significantly lower values for whole
kidney GFR and SNGFR, compared to values
obtained in control animals. Values for initial gb-
merular plasma flow rate (QA) in group II rats were
essentially similar to values observed in controls. On
the other hand, QA was moderately reduced in group
III rats, Therefore, the markedly lower values for
SNGFR observed in both groups of gentamicin-treat-
ed rats imply impairment in one or more of the
determinants of ultrafiltration other than QA.
In group II rats, the lower values of SNGFR,
relative to controls, appear to be almost exclusively
the result of the marked reductions in the ultrafiltra-
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Fig. 2. Llectron micrograp/is a! ,epresenfutile sect/u.s p1 the giomertilar capillary Ira/I Iioin a no,nial control aninial ( a), (i/id annuaLs
treated fir ten days with gentamicin at o dose of4 ,ng/kg/day (b) or4O mg/kg/day (c). No clearly identifiable differences were found among
groups for any of the component layers of the capillary wall. Endothelial layer is denoted as End; glomerular basement membrane, as BM;
and epithelial cell layer, as E. Magnification is x45,000.
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Fig. 3. Electron micrographs of representative sections of proximal tubule cells from a normal control animal (a,), and from animals treated
with low (b) and high (c) doses of gentamicin. Lysosomes (thin arrows) were present in all three groups of animals but contained myeloid
bodies (thick arrows) only after gentamicin treatment. These lysosomal changes, and focal degeneration of brush border (c, right upper
corner), were most prominent in the high dose group. Magnification is x8,500.
tion coefficient, Kf, since the change in QA was small
and values for and CA were similar to those
observed in group I control rats. Animals treated
with the higher dose of gentamicin exhibited slightly
but significantly lower values for whole kidney GFR
and slightly, but not significantly, lower values for
SNGFR than were observed in group II, although
the mean reduction in K1 (to about 50%of the control
minimum value) was almost identical for groups II
and III. The additional effects of the small reductions
in QA and iP observed in group Ill rats are therefore
responsible for the slightly greater decline in filtra-
tion rate, relative to group II.
That the reduction in GFR observed in these stud-
ies also reflects a functional impairment in GFR in
the awake animal is supported by studies of others in
which blood urea nitrogen and serum creatinine lev-
els were found to increase within 10 to 12 days from
onset of the daily administration of gentamicin, at
doses similar to those given in this study [7, 8, 10,
121.
Morphologic studies of the glomerular capillary
wall were undertaken in similarly treated rats in
order to determine whether an ultrastructural basis
for the declines in K1 could be found. K1 is defined as
the product of the hydraulic permeability of the gb-
merular capillary wall and the total surface area
available for filtration; the observed declines in K1
could therefore be due to reductions in either or both
of these quantities. Use of conventional electron
microscopic techniques, however, failed to demon-
strate any apparent differences between groups in
the ultrastructure of the three component layers of
the gbomerular capillary wall (endothelium, glomeru-
lar basement membrane, or epithelial cell layer), an
observation similar to that reported by others [7, 9,
121. It is possible, nonetheless, that biochemical or
minor morphological changes in glomerular cell vol-
ume, diameters of endothelial fenestrae and/or epi-
thelial slit diaphragm configuration too slight to be
distinguished from the inherent minor variations
related to tissue fixation may have escaped detec-
•' 'dl '
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tion. Therefore, more exacting morphometric studies
are needed, especially to ascertain whether the fall in
K is mediated by a reduction in total filtering surface
area.
Ultrastructurally, proximal tubule epithelia in both
groups of gentamicin-treated rats exhibited the char-
acteristic features of gentamicin-induced nephrotox-
icity [5, 7—10, 12, 14, 15], namely, appearance of
myeloid bodies, an abnormally large number of cell
vacuoles, and focal loss of the brush border. Proxi-
mal tubule lesions tended to be more pronounced in
rats receiving the high dose of gentamicin, a finding
in accord with the dose-dependent tubule injury
reported by others as well [5, 8, 9, 14, 15]. There
was, however, no morphologic evidence of necrosis
of proximal tubule cells in either group of gentami-
cm-treated rats in the present study. In spite of the
extensive tubule cell damage, particularly in the high
dose treatment group, there was no evidence for
altered permeability of the tubule to inulin, as mea-
sured in microinjection studies.
Measurements were not performed in the present
study to ascertain whether gentamicin-treated rats
were polyuric prior to anesthesia and preparation for
micropuncture. Urine flow rates were similar, how-
ever, in the three groups of rats studied at the time of
micropuncture. Observations by Kosek, Mazze, and
Cousins [8] have shown that rats given gentamicin at
a dose of 40 mg/kg/day for 12 days exhibit an average
decline in maximum urine osmolality of —50%,
implying that the effect of this dose of gentamicin on
urine flow rate is likely to be mild, rather than
pronounced.
In summary, therefore, administration of gentami-
cm to the Munich-Wistar rat in doses of both 4 and 40
mg/kg of body wt per day for ten days produces
morphologic and functional renal defects similar to
those previously characterized by others for nan and
several species of experimental animals. The mecha-
nism by which GFR is reduced with gentamicin
administration, at least with the doses investigated in
the present study, appears to be due primarily to a
drug-induced reduction in the glomerular capillary
ultrafiltration coefficient, Kf. This previously unre-
cognized basis for the decline in GFR which occurs
with gentamicin administration may also underlie the
impairment in filtration observed clinically with other
nephrotoxic antibiotics as well.
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